2026-01-27 - Analysis Report
**Company Overview**
IBM is an American multinational technology company that manufactures and sells computer hardware, software, and services.

**Return Rate Comparison**

* Cumulative Return of Review Stock (IBM): 155.62%
* Cumulative Return of Comparison Stock (S&P 500, VOO): 127.58%
* Divergence (max: 53.20, min: -80.70, current: 25.90, relative divergence: 79.60%)

The cumulative return of IBM is higher than the S&P 500, indicating a significant outperformance. However, the relative divergence of 79.60% indicates that this outperformance is within the top 90th percentile of past data.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -19.0% | 24.8% | -27.0% | 0.9 | 101.6B |
| 2017-2019  | -20.0% | 24.8% | -45.0% | 1.0 | 119.8B |
| 2018-2020  | -12.0% | 37.5% | -35.0% | 1.0 | 112.5B |
| 2019-2021  | 19.0% | 37.5% | -45.0% | 0.9 | 124.9B |
| 2020-2022  | 17.0% | 37.5% | 13.0% | 0.8 | 131.7B |
| 2021-2023  | 53.0% | 15.2% | 35.0% | 0.5 | 152.9B |
| 2022-2024  | 81.0% | 15.7% | 52.0% | 0.6 | 205.5B |
| 2023-2025  | 137.0% | 19.1% | 61.0% | 0.7 | 276.9B |

**Stock Price Fluctuations**

* Close: $296.33
* Last-Market Change: +1.33%
* 5-day SMA: $294.47
* 20-day SMA: $300.10
* 60-day SMA: $303.29

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 50.74
* PPO: -0.30
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: -2.80 (-)
* 7-day Rank change: -12 (-): rank down
* 7-day Dynamic Expected Return change: 0.50 (+): improving
* Expected Return (%): -6.10%

**News & Significant Events**

2026-01-26: IBM stock price eyes a parabolic move ahead of its earnings - TradingView
2026-01-21: Buy The Dip In IBM Stock? - Forbes
2026-01-21: Dear IBM Stock Fans, Mark Your Calendars for January 28 - Barchart.com
2026-01-26: IBM Shares Gain Ahead of Quarterly Report - AD HOC NEWS
2026-01-22: Should You 'Buy' or 'Sell' IBM Stock Ahead of Q4 Earnings? - Yahoo Finance
2026-01-26: IBM stock rating reiterated at Underperform by Evercore ISI ahead of earnings - Investing.com Nigeria

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
- Opinions: 19
- Target Price (avg/high/low): 305.16 / 375.00 / 210.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-23 | 1.87 | 16.33B |
| 2025-07-24 | 2.36 | 16.98B |
| 2025-04-24 | 1.14 | 14.54B |
| 2024-10-30 | -0.36 | 14.97B |
| 2025-10-23 | -0.36 | 14.97B |

**Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

**Comprehensive Analysis**

Overall, IBM's stock has shown significant outperformance compared to the S&P 500, with a cumulative return of 155.62%. However, the relative divergence of 79.60% indicates that this outperformance is within the top 90th percentile of past data. The stock's price fluctuations have been stable, with a recent increase in the past day. The RSI and PPO indicators suggest a neutral market risk, while the hybrid signal suggests a buy signal with 0% cash allocation. The 7-day rank change and dynamic expected return change are negative and positive, respectively. The expected return is -6.10%, indicating a potential long-term investment.

Based on the earnings analysis, IBM's revenue has been increasing over the past years, with a high profit margin in the most recent quarter. The company's capital and profitability have also been improving, with a significant increase in equity and a high ROE in the most recent quarter.

Overall, the comprehensive analysis suggests that IBM is a potentially attractive investment opportunity, with a strong outperformance compared to the S&P 500 and a stable price fluctuation. However, the risk level is classified as medium, and the expected return is negative, indicating a potential long-term investment with caution.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.